Achieving a true understanding of the illness

experience requires qualitative research methods to explore patients’ experiences from an emic perspective [22], yet qualitative studies exploring the needs and experiences of HIV patients in the region are lacking [23,24]. In particular, the multidimensional burden associated with living with HIV and how HIV services respond to this Inhibitors,research,lifescience,medical burden has not been described. Evidence in this area is essential to model appropriate services that meet mandated Selleckchem OSI744 guidelines for integrated HIV and palliative care. This study aimed to describe the palliative care needs of HIV outpatients and the management of multidimensional problems by HIV outpatient services in Kenya and Uganda, to inform the provision of HIV care and support in sub-Saharan Inhibitors,research,lifescience,medical Africa. Methods Study design Qualitative semi-structured interviews were conducted with HIV outpatients, informal caregivers and healthcare staff during the PEPFAR (President’s Emergency Plan for AIDS Relief) Care and Support public health evaluation (Phase 2) [25]. Setting The study was set in Kenya and Uganda. The Kenyan and Ugandan contexts represent the modern HIV epidemic, with moderate to high coverage of ART (61% in Kenya, 47% in Uganda [1]), stable prevalence [26] (6.3% in Kenya, 6.5% in Uganda [27]), and relatively good access to healthcare in urban areas [28]. Sites and participants Inhibitors,research,lifescience,medical Six facilities

were selected in each country (see Table 1 for facility characteristics). These facilities

were the largest of the 60 that were randomly selected from the c.1200 facilities receiving Inhibitors,research,lifescience,medical PEPFAR HIV Care and Support funding in Kenya and Uganda during Phase 2 of the PEPFAR evaluation [25]. Facility exclusion criteria were offering paediatric-only care and inaccessibility (e.g. insecure, no road access). Table 1 Characteristics of facilities In both countries, all facilities had full time doctors. Strong opioids were available at half of the Ugandan facilities but none of the Kenyan facilities. In Kenya, only two facilities (A, E) had any specialist spiritual Inhibitors,research,lifescience,medical care staff and only two (D, F) had any specialist psychological support staff. In Uganda, three facilities Linifanib (ABT-869) (G, K, M) had spiritual care staff and all facilities had specialist psychological support staff. For further details of the participating services, see Phase 2 reports [29,30]. We aimed to recruit seven patients, three caregivers and five staff at each site, providing an overall target of 84 patients, 36 caregivers and 60 staff members across both countries. Eligible participants for the patient interviews were adult patients (at least 18 years old) diagnosed with HIV infection who had been under the facility’s care for at least six weeks and were not involved in the Phase 1 cohort study also conducted during the PEPFAR study (not reported here) [25].